Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 669 citations

Medicine, Pharmacology, Pharmacotherapy +17

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

David A. Evans, A. Mahgoub, T.P. Sloan et al. · Journal of Medical Genetics · 1980 · 540 citations · Full text

Life Sciences, Genetics, Pharmacology +17

A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

David T. Wong, Penny G. Threlkeld, Kevin L. Best et al. · Journal of Pharmacology and Experimental Therapeutics · 1982 · 194 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Polymorphic debrisoquin hydroxylation in 757 Swedish subjects

Eugen Steiner, Leif Bertilsson, Juliette Säwe et al. · Clinical Pharmacology & Therapeutics · 1988 · 133 citations

Pharmacy, Pharmacology, Toxicology +12

Identification of the Human Cytochromes P450 Responsible for Atomoxetine Metabolism

Barbara J. Ring, Jennifer S. Gillespie, James A. Eckstein et al. · Drug Metabolism and Disposition · 2002 · 132 citations

Medicine, Pharmacology, Toxicology +17